J&J’s Gorsky Hails Strong Performance By Immunology Therapies Tremfya, Stelara

 
• By Joseph Haas
  
A money bill drawn on a chalk board looking like a growth graph with an upwards pointing arrow symbolizing economic relationships.
J&J reported continued strong growth for Stelara, Tremfya
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business